Kellie Combs, Ropes & Gray life sciences partner, analyzes three documents released by the FDA outlining the agency’s current thinking regarding drug and device manufacturers’ communication of information not contained in FDA-approved labeling.
Trending Similar Videos
Value-based health care: fraud & abuse laws
Michael Lampert, Ropes & Gray health care partner, discusses fraud and abuse law application to value-based health care arrangements.
Changing values of IP and data in deals
Ed Black, co-head of Ropes & Gray’s IP transactions and technology, media & telecommunications practice groups, discusses changing values of IP and data in M&A transactions.
Value-based health care: provider integration
John Chesley, Ropes & Gray health care partner, addresses developments for providers to consider as they integrate and move towards value-based health care models.
Value-based health care: private equity investors
Deborah Gersh, Ropes & Gray health care partner, discusses considerations for private equity companies investing in the value-based health care space.
Value-based health care: the role of payors
Bill Knowlton, Ropes & Gray health care partner, examines the critically important role of payors in value-based health care programs.
M&A auction process
Phil Sanderson, Ropes & Gray private equity transactions partner, discusses the M&A auction process in the UK.